This guide has been developed by a multidisciplinary and inter-institutional team, through a process of adaptation to local and national conditions of international clinical practice guidelines on this topic.
This guide considers new risks, in particular the risk of false positives and over-diagnosis for each age group, establishing a balance with the benefits of diagnosis and prevention practices.
An update of the national epidemiological information is included in this second edition.
To access the document, click on the image:
–
Related posts:
Report Immediately If Experiencing Any Unusual Symptoms After Immunization
Flu and corona vaccination: Vaccination history: What do pharmacists have to ask?
Facts about the Corona C.1.2 Variant from South Africa, Potentially More Contagious than Delta?
Confirm the suitable to "illness screening" between the working age teams 25-59 years
